14 results
PRE 14A
GLTO
Galecto Inc
16 Apr 24
Preliminary proxy
4:00pm
Biopharmaceuticals, Inc., later acquired by Allergan plc, from August 2005 to January 2011, and held multiple leadership positions at Amgen Inc. from September … and governance performance.
Leadership Structure and Risk Oversight
Our Board of Directors is currently chaired by Carl Goldfischer, M.D. The Board
DEF 14A
wja eiy3t
14 Apr 21
Definitive proxy
7:00am
10-K
8tmrtt pwalsk48qn
29 Mar 21
Annual report
6:03am
8-K
EX-99.1
heudsx9js1i7
8 Jan 21
Galecto Appoints Anne Prener to its Board of Directors
8:15am
10-Q
grvy85ta1tgn44dex
11 Dec 20
Quarterly report
7:30am
424B4
q50j8f53
30 Oct 20
Prospectus supplement with pricing info
4:31pm
S-1/A
i6nl2v nji8
22 Oct 20
IPO registration (amended)
6:13am
S-1
wlukb35jr30st071ow
7 Oct 20
IPO registration
5:01pm
DRS
bjlwz2slaq0pjw4dv
2 Sep 20
Draft registration statement
12:00am
- Prev
- 1
- Next